This research aims at developing meta-indicators (hereinafter referred to as PPRI indicators) for describing and analysing medicine pricing and reimbursement systems in European countries and beyond and making them available in a public database. The overall objective is to increase access to medicines for patients by providing accurate comparative country information on pharmaceutical systems for policy-makers and other stakeholders.